Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 496-500 , October 2005

Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection

References 

  1. Zurrida S, Orecchia R. Axillary radiotherapy instead of axillary dissection: a randomized trial. Ann Surg Oncol. 2002;9:156–160
  2. Veronesi U, Paganelli G. A randomized comparison of SLN biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–553
  3. Fisher B, Jong-Hyeon J. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567–575
  4. Louis-Sylvestre C, Clough K. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol. 2004;22:97–101
  5. Greco M, Agresti R. Breast cancer patients treated without axillary surgery. Clinical implications and biologic analysis. Ann Surg. 2000;232:1–7
  6. Kuznetsova M, Graybill J. Omission of axillary lymph node dissection in early-stage breast cancer: effect on treatment outcome. Radiology. 1995;197:507–510
  7. Fujimoto N, Amemiya A. Treatment of breast carcinoma in patients with clinically negative axillary lymph nodes using radiotherapy versus axillary dissection. Cancer. 2004;101:2155–2163
  8. Schlembach P, Buchholz T. Relationship of sentinel and axillary level I–II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys. 2001;51:671–678
  9. Chung M, DiPetrillo T. Treatment of the axilla by tangential breast radiotherapy in women with invasive breast cancer. Am J Surg. 2002;184:401–402
  10. Takeda A, Shigematsu N. The modified tangential irradiation technique for breast cancer: how to over the entire axillary region. Int J Radiat Oncol Biol Phys. 2000;46:815–822

☆ Sources of funding: The Italian Association for Cancer Research (AIRC).

☆☆ For correspondence: Professor U Veronesi, Istituto Europeo di Oncologia, Via G. Ripamonti 435, 20141 Milan, Italy. Email: umberto.veronesi@ieo.it.

☆☆☆ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(05)00131-3

doi: 10.1016/j.ctrv.2005.07.004

Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 496-500 , October 2005

Article Tools